146 related articles for article (PubMed ID: 12142597)
1. Topical platelet-derived growth factor enhances wound closure in the absence of wound contraction: an experimental and clinical study.
Saba AA; Freedman BM; Gaffield JW; Mackay DR; Ehrlich HP
Ann Plast Surg; 2002 Jul; 49(1):62-6; discussion 66. PubMed ID: 12142597
[TBL] [Abstract][Full Text] [Related]
2. Topical platelet-derived growth factor in patients enhances wound closure in the absence of wound contraction.
Ehrlich HP; Freedman BM
Cytokines Cell Mol Ther; 2002; 7(3):85-90. PubMed ID: 12850807
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of platelet-derived growth factor BB in accelerating wound healing in aged versus young animals: the impact of tissue hypoxia.
Wu L; Brucker M; Gruskin E; Roth SI; Mustoe TA
Plast Reconstr Surg; 1997 Mar; 99(3):815-22; discussion 823-4. PubMed ID: 9047202
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A2A receptor agonists promote more rapid wound healing than recombinant human platelet-derived growth factor (Becaplermin gel).
Victor-Vega C; Desai A; Montesinos MC; Cronstein BN
Inflammation; 2002 Feb; 26(1):19-24. PubMed ID: 11936752
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human platelet-derived growth factor enhanced dermal wound healing by a pathway involving ERK and c-fos in diabetic rats.
Cheng B; Liu HW; Fu XB; Sun TZ; Sheng ZY
J Dermatol Sci; 2007 Mar; 45(3):193-201. PubMed ID: 17270401
[TBL] [Abstract][Full Text] [Related]
6. Becaplermin: recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcers.
Nagai MK; Embil JM
Expert Opin Biol Ther; 2002 Feb; 2(2):211-8. PubMed ID: 11849120
[TBL] [Abstract][Full Text] [Related]
7. Original articles: ease of wound closure as an endpoint of treatment efficacy.
Robson MC; Maggi SP; Smith PD; Wassermann RJ; Mosiello GC; Hill DP; Cooper DM
Wound Repair Regen; 1999; 7(2):90-6. PubMed ID: 10231510
[TBL] [Abstract][Full Text] [Related]
8. PDGF-BB does not accelerate healing in diabetic mice with splinted skin wounds.
Park SA; Raghunathan VK; Shah NM; Teixeira L; Motta MJ; Covert J; Dubielzig R; Schurr M; Isseroff RR; Abbott NL; McAnulty J; Murphy CJ
PLoS One; 2014; 9(8):e104447. PubMed ID: 25121729
[TBL] [Abstract][Full Text] [Related]
9. Influence of platelet-derived growth factor on microcirculation during normal and impaired wound healing.
Uhl E; Rösken F; Sirsjö A; Messmer K
Wound Repair Regen; 2003; 11(5):361-7. PubMed ID: 12950640
[TBL] [Abstract][Full Text] [Related]
10. Preclinical promise of becaplermin (rhPDGF-BB) in wound healing.
LeGrand EK
Am J Surg; 1998 Aug; 176(2A Suppl):48S-54S. PubMed ID: 9777972
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor and wound contraction in the rat.
Karr BP; Bubak PJ; Sprugel KH; Pavlin EG; Engrav LH
J Surg Res; 1995 Dec; 59(6):739-42. PubMed ID: 8538174
[TBL] [Abstract][Full Text] [Related]
12. Research of PDGF-BB gel on the wound healing of diabetic rats and its pharmacodynamics.
Li H; Fu X; Zhang L; Huang Q; Wu Z; Sun T
J Surg Res; 2008 Mar; 145(1):41-8. PubMed ID: 18082770
[TBL] [Abstract][Full Text] [Related]
13. Growth factors and chronic wound healing: past, present, and future.
Goldman R
Adv Skin Wound Care; 2004; 17(1):24-35. PubMed ID: 14752324
[TBL] [Abstract][Full Text] [Related]
14. Use of becaplermin in the closure of pharyngocutaneous fistulas.
Jakubowicz DM; Smith RV
Head Neck; 2005 May; 27(5):433-8. PubMed ID: 15776464
[TBL] [Abstract][Full Text] [Related]
15. Assessment of platelet-derived growth factor using A splinted full thickness dermal wound model in bearded dragons (Pogona vitticeps).
Keller KA; Paul-Murphy J; Weber EP; Kass PH; Guzman SM; Park SA; Raghunathan VK; Gustavsen KA; Murphy CJ
J Zoo Wildl Med; 2014 Dec; 45(4):866-74. PubMed ID: 25632675
[TBL] [Abstract][Full Text] [Related]
16. Human plasma fibronectin potentiates the mitogenic activity of platelet-derived growth factor and complements its wound healing effects.
Larivière B; Rouleau M; Picard S; Beaulieu AD
Wound Repair Regen; 2003; 11(1):79-89. PubMed ID: 12581430
[TBL] [Abstract][Full Text] [Related]
17. Commercially available topical platelet-derived growth factor as a novel agent to accelerate burn-related wound healing.
Travis TE; Mauskar NA; Mino MJ; Prindeze N; Moffatt LT; Fidler PE; Jordan MH; Shupp JW
J Burn Care Res; 2014; 35(5):e321-9. PubMed ID: 24476989
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant platelet-derived growth factor (Regranex) on wound closure in genetically diabetic mice.
Chan RK; Liu PH; Pietramaggiori G; Ibrahim SI; Hechtman HB; Orgill DP
J Burn Care Res; 2006; 27(2):202-5. PubMed ID: 16566566
[TBL] [Abstract][Full Text] [Related]
19. Use of becaplermin gel and Kollagen Medifil particles.
Tomaselli NL
J Wound Ostomy Continence Nurs; 2000 Nov; 27(6):319-20. PubMed ID: 11096412
[No Abstract] [Full Text] [Related]
20. Human wound contraction: collagen organization, fibroblasts, and myofibroblasts.
Berry DP; Harding KG; Stanton MR; Jasani B; Ehrlich HP
Plast Reconstr Surg; 1998 Jul; 102(1):124-31; discussion 132-4. PubMed ID: 9655417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
